PDL BioPharma, 4% 1feb2018, USD (Conv.) (FIGI BBG005Z1ZKP7, WKN A1ZDQQ)
国内債券, 転換社債
国内債券, 転換社債
|
PDL BioPharma (known as Protein Design Labs prior to 2006). PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery ...
PDL BioPharma (known as Protein Design Labs prior to 2006). PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
175 910
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡